A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This multi-center, observational study will evaluate the clinical practice patterns, efficacy
and safety of RoActemra/Actemra (tocilizumab) in participants with moderate to severe
rheumatoid arthritis. Data will be collected from each eligible participant initiated on
RoActemra/Actemra treatment by their treating physician according to local label for 6 months
from start of treatment.